Clinical Study

Motor Cortex Stimulation in Parkinson's Disease

Table 1

Changes of quality of clinical assessment in ten patients with advanced Parkinson's disease performed before motor cortex stimulation and after surgery at 6, 12, 24, and 36 months in off-medication/on-stimulation states.

Pre-MCS6-Months12-Months24-Months36-Months

UPDRS total
UPDRS II
UPDRS III
UPDRS IV
UPDRS III axial symptoms: items 27–31
LEDD (mg/die)
PDQoL-39

MCS: motor cortex stimulation; UPDRS: unified Parkinson disease rating scale; LEDD: L-dopa equivalent daily Dose; PDQoL-39: Parkinson’s disease quality of Life scale. P values calculated versus pre-MCS. .